Source: Transplantation Proceedings. Unidade: FM
Subjects: TRANSPLANTE DE FÍGADO, ANTICORPOS MONOCLONAIS, CRIANÇAS, FÁRMACOS IMUNOSSUPRESSORES (TERAPIA)
ABNT
GIBELI, N. E. M. et al. Baxiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver trasnplantation: comparative study. Transplantation Proceedings, v. 36, p. 956-957, 2004Tradução . . Acesso em: 12 jul. 2024.APA
Gibeli, N. E. M., Pinho-Azevedo, M. L., Miytani, H. T., Silva, M. M., Ayoub, A. A., Maksoud Filho, J. G., et al. (2004). Baxiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver trasnplantation: comparative study. Transplantation Proceedings, 36, 956-957.NLM
Gibeli NEM, Pinho-Azevedo ML, Miytani HT, Silva MM, Ayoub AA, Maksoud Filho JG, Santos MM, Tannuri U, Maksoud JG. Baxiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver trasnplantation: comparative study. Transplantation Proceedings. 2004 ; 36 956-957.[citado 2024 jul. 12 ]Vancouver
Gibeli NEM, Pinho-Azevedo ML, Miytani HT, Silva MM, Ayoub AA, Maksoud Filho JG, Santos MM, Tannuri U, Maksoud JG. Baxiliximab-chimeric anti-IL2-R monoclonal antibody in pediatric liver trasnplantation: comparative study. Transplantation Proceedings. 2004 ; 36 956-957.[citado 2024 jul. 12 ]